Vascular complications after splenectomy for hematologic disorders.
about
How I treat autoimmune lymphoproliferative syndromeRole of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopeniaContemporary management of primary immune thrombocytopenia in adultsThromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis.Consensus Paper-ICIS Expert Meeting Basel 2009 treatment milestones in immune thrombocytopeniaPathophysiology and management of chronic immune thrombocytopenia: focusing on what matters.[Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)].Sequence of treatments for adults with primary immune thrombocytopenia.Splenectomy and/or cyclophosphamide as salvage therapies in thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications?Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatmentSplenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopeniaImmune thrombocytopenia -- what are the new treatment options?Alternate considerations for current concepts in ITP.Rozrolimupab, a first-in-class recombinant monoclonal antibody product for primary immune thrombocytopaenia.Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials.Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors.A Seeming Paradox: Ischemic Stroke in the Context of Idiopathic Thrombocytopenic Purpura.Use of romiplostim in patients with chronic idiopathic thrombocytopenic purpura during perioperative period.Is ITP a thrombophilic disorder?Persistent thrombocytopaenia in a young man with splenomegaly, rebound thrombocytosis after splenectomy and subsequent pulmonary embolism: splenic littoral cell angioma and associated events.Comparative efficacy and cost effectiveness of splenectomy and thrombopoietin prior to peginterferon and ribavirin therapy with compensatory cirrhosis associated with hepatitis C and thrombocytopenia.Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies.Long-term complications of splenectomy in adult immune thrombocytopenia.Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia.Achieving a satisfactory clinical and biochemical response in antiphospholipid syndrome and severe thrombocytopenia with rituximab: two case reportsFatal pulmonary embolism following splenectomy in a patient with Evan's syndrome: case report and review of the literature.Management of postoperative complications following splenectomyFactors Influencing RBC Alloimmunization: Lessons Learned from Murine Models.Traditional laboratory measures of cardiovascular risk in hereditary spherocytosisClinical outcomes of splenectomy in children: report of the splenectomy in congenital hemolytic anemia registryPleiotropic effects of intravascular haemolysis on vascular homeostasis.Thrombocytosis following splenectomy and aortic valve replacement for idiopathic thrombocytopaenic purpura with bicuspid aortic valve.Long-term risk of acute coronary syndrome in splenectomized patients due to splenic injury.Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell diseaseIncreased Risk of Hemorrhagic and Ischemic Strokes in Patients With Splenic Injury and Splenectomy: A Nationwide Cohort StudyComments on 'clinical course of 63 children with hereditary spherocytosis: a retrospective study' - with the particular question: 'Should HS be treated the same way throughout the world?'.Giant right ventricular outflow tract thrombus in hereditary spherocytosis: a case reportBiomechanics of red blood cells in human spleen and consequences for physiology and diseaseHereditary hemolytic anemia in Korea from 2007 to 2011: A study by the Korean Hereditary Hemolytic Anemia Working Party of the Korean Society of Hematology.
P2860
Q24633207-74BE772E-EE2C-49FC-88B0-232CD08583E2Q26741269-516FFA67-EEBD-46A3-8715-8965A95D3EBCQ26853680-1E6A7CA2-4955-4E03-BE4F-6786FC342500Q30250259-1ED79EB7-EF5E-46C4-BB24-C171F56899AFQ33389001-ADA98337-1288-490A-AED6-C02357761691Q33392868-9A156AEB-777E-44F5-9B53-404FF0A75D30Q33400018-3FF29122-23AF-48ED-A608-E7A2321F6D89Q33400072-491AB6F6-A118-423D-9BA3-FA4B6968CBE3Q33400172-B580FB47-0F3D-478B-B78A-8C8C8362E248Q33401130-72845E67-9AE6-4279-947C-AF121E5AC0E7Q33403298-DD0BBBA0-2FFD-4F78-832B-8213D497D8D3Q33407451-95FEDE43-49C6-453E-BDFF-12EEA348BAC5Q33407802-691FA673-19B7-485C-860F-CA1D06CAB266Q33407813-0EFA06B5-CE0E-4962-9B93-DAAB708E3743Q33407831-3036943C-D759-4B83-90FF-7770254C1BE0Q33409611-50795002-AD81-475C-AF0A-4AB7FF0E434EQ33415996-BBE29340-6B83-4F80-8E1C-483D6F2596CAQ33417001-B9481270-CBF5-4320-A88D-21E78A8874E8Q33422277-AFA2E63C-7E3D-4659-A8E4-0D1B56D327A3Q33427394-F6F31F40-7BF1-45A0-8E3E-2EBA9159342AQ33427853-25676321-47C4-483D-90A6-40E9A214141CQ33428399-C6BABD6C-4393-486B-BC61-F0E68AD2A813Q33431551-AD1C5FB2-0924-4C4D-B646-8D17EA6A3DABQ33437227-6268C8B3-3837-47FF-AF7D-7405EF16DC66Q33441008-F2C4B2E5-47BE-42BA-9EFC-02B969620D8EQ33442480-A1C66DC7-2F1F-416F-B84F-44A22F5FA5B7Q33443338-866C0AF8-6ABD-47CF-B39D-67748D7A0176Q33457259-79CDF9BF-E1FB-48D1-AF2C-A22DFAC429E8Q34792041-56D5CC54-08DA-4205-A8B6-5B083A249F50Q34881629-7ACDF06D-7452-4987-BBEE-087D70A5F679Q35096956-B4FE946A-FAA6-48DD-989C-D4EDB38A9A12Q35535204-5A61E738-6B61-4DC1-8DE0-F5B2880A6816Q35999739-94DEDC59-FE1B-4329-A6B7-B147B630147EQ36008910-F22D5BE4-E9D9-41E8-83FC-A1975B2B7307Q36106316-6C7B38EC-DEBA-4B1F-AE3D-B6A0B84D3C59Q36194323-10765876-FA7E-46F8-B547-226D9E034CA1Q36283818-AF673F85-55C5-4940-8091-D6F45950E351Q36836684-F61D731A-0606-4A2B-89BD-E488D23A1311Q37102400-0CAE387A-E581-4083-96AF-E1B3A75ED84EQ37205602-3526CDB6-261D-4C16-B154-F5387E25F2EE
P2860
Vascular complications after splenectomy for hematologic disorders.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vascular complications after splenectomy for hematologic disorders.
@en
Vascular complications after splenectomy for hematologic disorders.
@nl
type
label
Vascular complications after splenectomy for hematologic disorders.
@en
Vascular complications after splenectomy for hematologic disorders.
@nl
prefLabel
Vascular complications after splenectomy for hematologic disorders.
@en
Vascular complications after splenectomy for hematologic disorders.
@nl
P2860
P1433
P1476
Vascular complications after splenectomy for hematologic disorders.
@en
P2093
George R Buchanan
Shelley E Crary
P2860
P304
P356
10.1182/BLOOD-2009-04-210112
P407
P577
2009-07-27T00:00:00Z